Growth Hormone and Neurogenesis

Grow Taller 4 Idiots

How to Grow Taller

Get Instant Access

GH also appears to play an important role in the newly described phenomenon termed neurogenesis, or new neuronal division in the CNS. A major mediator of the trophic effects of GH throughout the body is a mediating hormone, insulin-like growth factor-I (IGF-I), with increased gene expression of IGF-I through GH exposure (Pankov, 1999). It has been recently demonstrated that IGF-I has a clear stimulatory effect on both cell proliferation and neurogen-esis in the rodent hippocampus (Anderson, Aberg, Nilsson, & Eriksson, 2002), providing indirect confirmation of GH involvement in neurotrophic processes. Because it appears a range of antidepressant and mood stabilizing interventions increase neurogenesis, the blunted GH response to clonidine observed in PD, depression, and GAD should be considered within the context of GH-sensitive IGFs as promoters of neuroprotection and neurogenesis. Studies of GH secretion hyposecretion are therefore informative as a peripheral index of central neuroprotection and also a possible site for neuroprotective deficits in Mood and Anxiety Disorders.


Anderson, M. F., Aberg, M. A., Nilsson, M., & Eriksson, P. S. (2002). Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Research. Developmental Brain Research, 134, 115-122. Coplan, J. D., Papp, L. A., Martinez, J., Pine, D., Rosenblum, L. A., Cooper, T., et al. (1995). Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder. American Journal of Psychiatry, 152(4), 619-622.

Coplan, J. D., Pine, D., Papp, L., & Gorman, J. M. (1997). A window on noradrenergic, hypothalamic-pituitary-adrenal axis and corticotropin releasing-factor function in Anxiety and affective disorders: The growth hormone response to clonidine. Psychopharmacology Bulletin, 33(2), 193-204. Coplan, J. D., Smith, E. L., Trost, R. C., Scharf, B. A., Altemus, M., Bjornson, L., et al. (2000a). Growth hormone response to cloni-dine in adversely reared young adult primates: Relationship to serial cerbrospinal fluid corticotropin-releasing factor concentrations. Psychiatry Research, 95, 93-102. Coplan, J. D., Wolk, S. I., Goetz, R. R., Ryan, N. D., Dahl, R. E., Mann, J. J., et al. (2000ba). Nocturnal growth hormone secretion studies in adolescents with or without major depression reexamined: Integration of adult clinical follow-up data. Biological Psychiatry, 47(7), 594-604. Dinan, T. G. (1998). Psychoneuroendocrinology of depression: Growth hormone. In C. B. Nemeroff (Ed.), The psychiatric clinics of North America: Psychoneuroendocrinology (pp. 325-340). Holsboer, F. (1994). Neuroendocrinology of mood disorders. In F. E. Bloom & D. J. Kupfer (Eds.), Neuropsychopharmacology: The fourth generation of progress (pp. 957-970). New York: Raven Press.

Pankov, Y. A. (1999). Growth hormone and a partial mediator of its biological action, insulin-like growth factor I. Biochemistry, 64(1), 1-7.

Puig-Antich, J. (1987). Affective disorders in children and adolescents: Diagnostic validity and psychobiology. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 843-859). New York: Raven Press.

Scheepens, A., Sirimanne, E. S., Breier, B. H., Clark, R. G., Gluck-man, P. D., & Williams, C. E. (2001). Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience, 104(3), 677-687.

Siever, L. J., Uhde, T. W., Silberman, E. K., Jimerson, D.C., Aloi, J. A., Post, R. M., et al. (1982). Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Research, 6, 171-183.

Uhde, T. W., Tancer, M. E., Rubinow, D. R., Roscow, D. B., Bou-

lenger, J. P., Vittone, B., Gurguis, G., Geraci, M., Black, B., & Post, R. M. (1992). Evidence for hypothalamo-growth hormone dysfunction in Panic Disorder: Profile of growth hormone responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in Panic Disorder patients versus healthy volunteers. Neuropsychopharmacology, 6(2), 101-118.

Jeremy D. Coplan

Muhammad Arif

State University of New York, Brooklyn

Curtis Wittmann

Washington University in St. Louis School of Medicine

See also: Depression, Neurotransmitter

Was this article helpful?

0 0
Stop Anxiety Attacks

Stop Anxiety Attacks

Here's How You Could End Anxiety and Panic Attacks For Good Prevent Anxiety in Your Golden Years Without Harmful Prescription Drugs. If You Give Me 15 minutes, I Will Show You a Breakthrough That Will Change The Way You Think About Anxiety and Panic Attacks Forever! If you are still suffering because your doctor can't help you, here's some great news...!

Get My Free Ebook

Post a comment